Patient-Physician Discussions on Lung Cancer Screening
Lung cancer screening highlights the harms of smoking to patients who are chronic, heavy smokers and thus may serve as a teachable moment for promoting smoking cessation.
Importance of Smoking Cessation on Surgical Outcome
Smoking cessation is important in the management of patients who require pulmonary resection. However, the impact of short-term smoking cessation on the surgical outcome remains unclear.
Tobacco Cessation Counseling Coverage
An insurance resource to help you understand Medicaid, Medicare, and private insurance coverage for lung cancer screening with low-dose ct scan and shared decision making.
Treating Tobacco Use and Dependence: 2008 Update
The Quick Reference Guide for Clinicians contains strategies and recommendations from the Public Health Service-sponsored Clinical Practice Guideline Treating Tobacco Use and Dependence: 2008 Update.
Treating Smokers in the Health Care Setting
The decrease in smoking has recently stalled among those with low incomes, low educational attainment, psychiatric conditions, and certain ethnic groups. Smoking is a prime driver of healthcare expenditures for low income and other disadvantaged individuals.
Tobacco Dependence Predicts Higher Lung Cancer
Patients with high dependence scores were less likely to quit smoking compared with low dependence smokers. Indicators of high dependence, as measured according to all three metrics, were associated with worsening clinical outcomes.
Tobacco and Lung Cancer: Risks, Trends, and Outcomes
Tobacco use, primarily associated with cigarette smoking, is the largest preventable cause of cancer mortality, responsible for approximately one-third of all cancer deaths.
The Past, Present, and Future of Nicotine Addiction Therapy
This article reviews the evidence for combined and extended cessation pharmacotherapy and behavioral strategies.
The Importance of Incorporating Smoking Cessation into Lung Cancer Screening
Lung cancer is the leading cause of cancer-related death in the US and is the 2nd most common non-skin cancer, accounting for about 30% of cancer-related deaths.